Diversity of ion channel expression in health and disease

European Heart Journal, Supplement

Volumn 3, Issue K, 2001, Pages

  Kääb, Stefan ^a   Nabauer M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Arrhythmia; Heart failure; Hypertrophy; Ion channels; Repolarization; Sudden cardiac death

Indexed keywords

ANTIARRHYTHMIC AND ARRHYTHMIA-INDUCING AGENTS; CALCIUM ION; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM ION;

ACTION POTENTIAL; ARRHYTHMOGENESIS; CELL HETEROGENEITY; CONFERENCE PAPER; DISEASE ASSOCIATION; DOWN REGULATION; HEALTH STATUS; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROARRHYTHMIA; HEART REPOLARIZATION; HUMAN; HYPOKALEMIA; ION CURRENT; LONG QT SYNDROME; POTASSIUM CURRENT; PRIORITY JOURNAL;

EID: 0034811653     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90004-5     Document Type: Conference Paper

References (69)

1. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle
2. The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart
3. Ks are larger in right than left canine ventricular midmyocardium
4. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs. Clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology
5. Four different components contribute to outward current in rat ventricular myocytes
6. + currents in adult mouse ventricular myocytes
7. Transient outward current prominent in canine ventricular epicardium but not endocardium
8. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure
9. Time-dependent outward current in guinea pig ventricular myocytes. Gating kinetic of the delayed rectifier
10. Ks
11. + channel in ventricular muscle. A molecular correlate for the transient outward current
12. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle
13. + current. Differential sensitivity to block by class III antiarrhythmic agents
14. K, by flecainide and E-4031 in cat ventricular myocytes
15. + current in cardiac myocytes by dofetilide
16. Evidence for two components of delayed rectifier k+ current in human ventricular myocytes
17. Delayed rectifier potassium current in undiseased human ventricular myocytes
18. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure
19. + current on the guinea pig action potential
20. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin
21. Regional differences in current density and properties of the transient outward current in human ventricular myocytes
22. A second calcium-independent transient outward current present in human left ventricular myocardium
23. Isolation and characterization of the human gene encoding Ito: Further diversity by alternative mRNA splicing
24. Molecular basis of transient outward potassium current downregulation in human heart failure: A decrease in Kv4·3 mRNA correlates with a reduction in current density
25. Distinct transient outward potassium current (Ito) phenotypes and distribution of fast-inactivating potassium channel alpha subunits in ferret left ventricular myocytes
26. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
27. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure
28. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure
29. Arrhythmogenesis in experimental models of heart failure: The role of increased load
30. Sudden cardiac death in heart failure. The role of abnormal repolarization
31. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis
32. Depressed transmembrane potentials during experimentally induced ventricular failure in cats
33. +-currents in isolated human ventricular myocytes from patients with terminal heart failure
34. Cellular electrophysiology in cardiac hypertrophy and failure
35. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing
36. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function
37. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy
38. Cellular electrophysiologic basis of cardiac arrhythmias
39. Sodium Current in isolated human ventricular myocytes
40. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: Role of sustained inward current
41. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes
42. Electrophysiological remodeling in hypertrophy and heart failure
43. Subunit expression of the cardiac L-type calcium channel is differentially regulated in diastolic heart failure of the cardiac allograft
44. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: Experimental studies
45. Mechanisms of altered excitation-contraction coupling in caninc tachycardia-induced heart failure, II: Model studies
46. Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture
47. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes
48. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts
49. Potassium channel down-regulation in heart failure
50. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes
51. Arrhythmogenic properties of the ventricular myocardium in cardiomyopathic Syrian hamster, BIO 14.6 strain
52. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy
53. Outward currents in hypertrophied feline ventricular myocytes
54. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages
55. Membrane current changes in left ventricular myocytes isolated from guinea pigs after abdominal aortic coarctation
56. The effects of barium, dofetilide and LF-aminopyridine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart
57. Das herzinsuffizienz-model dutch schnelle schrittmacher-stimulation am kaninchen reproduziert grundlegende electropyhysiologische merkmale des insuffizienten menschlichen herzens
58. Stretch-induced changes in heart rate and rhythm: Clinical observations, experiments and mathematical models
59. Swelling-activated chloride current is persistently activated in ventricular myocytes from dogs with tachycardia-induced congestive heart failure
60. Cardiac hypertrophy and failure - A disease of adaptation. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity
61. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure
62. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy
63. Arrhythmias and mortality in congestive heart failure
64. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
65. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644
66. Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval
67. Electrical and mechanical characteristics of isolated ventricular myocytes from guinea-pigs with left ventricular hypertrophy and congestive heart failure
68. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival with oral d-sotalol
69. Increased mortality due to encainide or flecainide in a randomized trial of arrhythmia suppression after myocardial infarction